September 21, 2023 | Advisors, AdvisoryBoard, DOL, HCP, KOL, Online advisory board, Pharma, Virtual advisory board, digital advisory board
As part of our top 10 most important advisor questions that every brand team should keep in mind when designing virtual advisory board touchpoints, here’s another one to keep in mind:
5. Placement of Your Product in the Current and Future Treatment Algorithm
What are the current and potential places of your product in the treatment algorithm for specific patient populations? What factors (e.g. demographic, clinical, and regulatory/reimbursement factors, new data, or loss of exclusivity) may affect this?
Learn the other questions by reading our blog:
https://www.impetusdigital.com/2020/02/03/top-10-most-important-advisor-questions/
For more information on how we can help you engage your advisors, HCPs, patients, and stakeholders, visit us at www.impetusdigital.com or talk to one of our amazing team members via https://meetwithimpetus.com/
Follow us on social media
https://linkedin.com/company/impetus-digital
https://twitter.com/impetus_digital
https://facebook.com/ImpetusDigital.fb
https://impetusdigital.com/podcast/
This content was provided by Impetus Digital
Company Details
Latest Content from Impetus Digital
This quick video covers #9 of our Top 10 Most Important Advisor Questions, shedding light on the complexities of local and national regulatory issues in the Pharma and Life Sciences...
Register now for one of our upcoming webinars (February 26-28)
In this quick clip, we highlight a vital tip from our 'Top 10 Most Important Advisor Questions' – essential for enhancing your virtual collaboration strategies in Pharma and Life Sciences....
Learn how our client executed a series of 3 virtual touchpoints with 5 rare disease patient advocates to:- Develop a better understanding of the current treatment landscape and lived patient...
In this video, we explore another crucial aspect of advisor questions when developing your virtual advisory board touchpoints – a key component for success in today's diverse healthcare landscape. 7....
Join us for a look at the top-5 emerging virtual collaboration trends...
As part of our top 10 most important advisor questions that every brand team should keep in mind when designing virtual advisory board touchpoints, here's another one to keep in...
Although orphan drugs represent a sizeable portion of new drug approvals, most rare diseases still lack effective treatment. Even more so than for other conditions, rare disease management contains large care...
Here's another great tip on why the benefits of virtual advisory boards are superior to in-person and hybrid advisory boards. #10. Versatility! Another major advantage of using a virtual platform...
In the early lead-up to our client’s multi-center Rare Disease Phase 3 Clinical Trial, they first conducted an internal engagement planning Longitudinal Expert Engagement Plan™ (LEEP™) to conduct an informal...